DIRS.INFO The most relevant business & tech news

☆ Stocks making the biggest moves midday: Beyond Meat, Live Nation, Yeti, Boeing and more
▼ + stars: | 2023-02-24 | by ( Michelle Fox | ) www.cnbc.com time to read: +3 min

Live Nation — The ticker seller fell 9%, despite reporting fourth-quarter revenue of $4.29 billion, up about 60% year over year and topping StreetAccount's estimate of $3.6 billion. EOG Resources — The energy company dropped 5.1% after reporting fourth-quarter earnings, excluding items, that were short of analysts' expectations, according to StreetAccount. Etsy — Etsy slipped 4.8%, a day after gaining more than 2% on its fourth-quarter earnings beat. The company also offered cautious guidance for its first quarter, anticipating $2.95 billion to $3.15 billion in gross merchandise revenue. However, Autodesk beat fourth-quarter expectations on the top and bottom lines, according to Refinitiv.

☆ Stocks making the biggest moves midday: Domino's Pizza, Lucid, Nvidia, Nikola and more
▼ + stars: | 2023-02-23 | by ( Sarah Min | ) www.cnbc.com time to read: +3 min

Lucid Group — The electric vehicle maker tumbled more than 18% after posting fourth-quarter revenue that fell short of analysts' expectations. Mosaic Company — Shares of the fertilizer mineral company added 1.4% on Thursday after Mosaic's quarterly revenue came in higher than expected. The company generated $4.48 billion in revenue, while analysts surveyed by StreetAccount were expecting $4.17 billion revenue. Domino's Pizza , Papa John's International — The pizza chains fell 11% and 7.6%, respectively, after they reported mixed earnings. Nikola — Shares fell more than 7% after Nikola reported quarterly revenue that disappointed analyst expectations.

☆ Stocks making the biggest moves premarket: Lucid, Nvidia, Dollar General, Sunrun and more
▼ + stars: | 2023-02-23 | by ( Tanaya Macheel | ) www.cnbc.com time to read: +4 min

Lucid Motors — The electric vehicle maker saw shares slide 14% premarket after reporting that fourth-quarter revenue fell short of expectations. eBay — The online auction platform fell 5% despite posting fourth-quarter earnings and revenue that topped analysts' estimates as gauged by Refinitiv. The company also forecast current quarter revenue of $600 million and $640 million, compared to estimates of $622 million. Bath & Body Works — Shares fell more than 4% after the company reported fourth-quarter earnings. Sunrun — The solar company rose 1.5% after its fourth-quarter earnings topped Wall Street's expectations.

☆ Stocks making the biggest moves after hours: Nvidia, Etsy, Lucid, Bumble, Moderna and more
▼ + stars: | 2023-02-22 | by ( Tanaya Macheel | ) www.cnbc.com time to read: +2 min

Etsy posted revenue of $807 million, smashing estimates of $752 million, according to Refinitiv. The company also forecast current quarter revenue of $600 million and $640 million, compared to estimates of $622 million. eBay — The online auction platform reported fourth quarter earnings of $1.07 per share excluding items, on revenues of $2.51 billion. Bumble — The online dating site jumped nearly 5% after it reported better-than-expected fourth quarter earnings and revenue. Bumble posted revenue of $191 million, above the $186 million estimated by analysts polled by FactSet.

☆ Stocks making the biggest moves midday: Deere, Airbnb, AutoNation, Moderna and more
▼ + stars: | 2023-02-17 | by ( Michelle Fox | ) www.cnbc.com time to read: +3 min

Check out the companies making the biggest moves midday:Deere — Shares rose 7.7% after the company reported earnings-per-share of $6.55 for its fiscal first quarter, topping the $5.57 expected by analysts polled by Refinitiv. Some Wall Street analysts remained cautious on the stock, citing risks including competition and slower-than-expected consumer adoption of alternative accommodations. Still, earnings and revenue missed Wall Street estimates. The sports betting company reported a loss of 53 cents per share on revenue of $855 million. The real estate company reported a 57 cent per share loss on $480 million of revenue.

☆ Stocks making the biggest moves after hours: DoorDash, Applied Materials, DraftKings and more
▼ + stars: | 2023-02-16 | by ( Hakyung Kim | ) www.cnbc.com time to read: +2 min

Reported losses, however, were greater than analysts' projections, coming in at a per-share loss of $1.65 versus analysts' estimates of 68 cents. Revenue came in at $1.01 billion, missing analysts' estimates of $1.02 billion. DraftKings — The sports betting company's shares gained 6% after its fourth-quarter earnings and revenue exceeded analysts' estimates. Applied Materials — The semiconductor company's stock added about 2% after Applied Materials posted its latest results. Revenue was $6.74 billion in the same quarter, beating analysts' estimates of $6.69 billion.

☆ Stocks making the biggest moves midday: Carvana, Colgate-Palmolive, Tesla and more
▼ + stars: | 2023-01-30 | by ( Pia Singh | ) www.cnbc.com time to read: +2 min

Tesla — Shares dropped 2.8% after Berenberg lowered its earnings estimate for Tesla by around 25% for 2023 following the company's price cuts for its electric vehicles. Ford Motor Company — Shares fell nearly 1.4% after the company announced price cuts for its electric Mustang Mach-E crossover. The move in Ford comes after Tesla said earlier this month it would trim prices to counteract dwindling demand. AMC Entertainment — Common shares of the theater chain fell by more than 7% after AMC announced a shareholder meeting in March for a potential change to its capital structure. The preferred or "APE" shares, which trade at a large discount to the common shares, jumped by more than 16%.

☆ Stocks making the biggest moves midday: American Express, Intel, Silvergate Capital and more
▼ + stars: | 2023-01-27 | by ( Tanaya Macheel | ) www.cnbc.com time to read: +3 min

Colgate-Palmolive — Shares fell more than 4% after Colgate-Palmolive released its latest earnings results. The guidance came even as the company reported earnings that beat on top and bottom lines. Visa — The payments stock rose by more than 2% after a better-than-expected fiscal first quarter. Analysts surveyed by Refinitiv had expected earnings of $2.01 per share on revenue of $7.7 billion. Net revenue rose 12% year over year, with total cross-border volume climbing 22%.

☆ Stocks making the biggest moves midday: Microsoft, Moderna, Mobileye, Chegg and more
▼ + stars: | 2023-01-18 | by ( Sarah Min | ) www.cnbc.com time to read: +3 min

The company reported fourth-quarter results fell short of analysts' expectations on both top and bottom lines, according to StreetAccount. Chegg — Shares fell 15% after Needham downgraded Chegg to hold from buy, saying the online education company will have trouble reaching consensus for full-year revenue growth in Chegg Services, according to StreetAccount. Mobileye — Shares of the assisted driving company gained 8% after Deutsche Bank initiated coverage of the stock as a buy. Oatly Group — Shares of Oatly Group fell nearly 2%, losing steam after Mizuho upgraded the stock to buy from neutral. Hancock Whitney — Shares fell more than 4% after the bank reported earnings that came mostly in line with expectations, but net interest income came in below expectations, according to StreetAccount.

☆ Stocks making the biggest moves midday: Gilead Sciences, Moderna, Tesla and more
▼ + stars: | 2022-12-20 | by ( Michelle Fox | ) www.cnbc.com time to read: +3 min

A sign is posted in front of the Gilead Sciences headquarters on April 29, 2020 in Foster City, California. Check out the companies making the biggest moves midday:General Mills — General Mills dropped 4.2%, despite reporting better-than-expected revenue and profit for the last quarter. Gilead Sciences — Gilead Sciences sank 2.4% after announcing its Kite unit would acquire biotech company Tmunity Therapeutics. Tesla – Shares of Tesla sank 5.3% after Evercore ISI lowered its price target on them, citing concerns as the stock failed to hold a key level. Arch Capital — The Bermuda-based insurance company rose 2.5%.

☆ Stocks making the biggest moves midday: SoFi Technologies, Charter Communications, Delta and more
▼ + stars: | 2022-12-14 | by ( Michelle Fox | ) www.cnbc.com time to read: +3 min

Check out the companies making the biggest moves midday:SoFi Technologies — The fintech stock jumped more than 7% after a filing showed CEO Anthony Noto bought $5 million in common stock. Charter Communications — Charter Communications dropped more than 13% after CEO Chris Winfrey said at an investor event the company will invest $5.5 billion over three years to upgrade its high-speed internet network. Morgan Stanley said it was a top auto pick for 2023. RingCentral — Shares of RingCentral climbed 4.8% after being upgraded by Morgan Stanley to overweight from equal weight. In its call, Morgan Stanley said the software company is underappreciated.

☆ Stocks making the biggest moves midday: Snap, American Express, Verizon, Twitter and more
▼ + stars: | 2022-10-21 | by ( Samantha Subin | ) www.cnbc.com time to read: +4 min

Snap — Shares of the Snapchat parent company cratered 30% after missing revenue estimates and sharing its slowest sales growth since going public as advertising spending slows. The results from Snap hit other ad-reliant stocks, sending shares of Pinterest and Meta Platforms down about 7.7% and 2.6%, respectively. Twitter — The social media stock sank more than 4% Friday amid a slew of media reports surrounding Twitter and Elon Musk. American Express – Shares of American Express fell about 3.5% even after the bank reported quarterly earnings and revenue that beat analysts' expectations. Huntington Bancshares — Shares gained 8% after the bank operator topped earnings estimates for the third quarter and upped its net interest income outlook for 2022.

☆ Stocks making the biggest moves midday: Moderna, Pepsi, Lyft and more
▼ + stars: | 2022-10-12 | by ( Michelle Fox | ) www.cnbc.com time to read: +3 min

Pepsi products are displayed for sale in a Target store on March 8, 2022 in Los Angeles, California. Check out the companies making the biggest moves midday Wednesday:Moderna — Shares of Moderna surged 10% after the drug maker announced it will partner with Merck to jointly develop and sell a cancer vaccine. It reported preliminary month-end assets under management of $1.23 trillion as of Sept. 30. Pepsi also raised its guidance for the year as it was able to successfully raise prices on its products. Lyft — Lyft shares gained 5.8% following an upgrade from Gordon Haskett to buy from hold.

☆ Pfizer or Moderna: Which new omicron-specific Covid booster should you get?
▼ + stars: | 2022-09-27 | by ( Annika Kim Constantino | ) www.cnbc.com time to read: +3 min

Americans have two options for a new omicron-specific Covid booster shot: Pfizer or Moderna. Pfizer's booster is cleared for anyone 12 and older, while Moderna's booster is for people 18 and older. "People ages 18 years and older may get a different product for a booster than they got for their primary series, as long as it is [Pfizer or Moderna,]" the CDC's website reads. "It's OK to mix and match Moderna and Pfizer," Dr. Ralph Gonzales, associate dean for clinical innovation at UC San Francisco, said at a campus town hall earlier this month. I definitely felt a stronger response with the Moderna — having had Pfizer before — but either combinations are fine."

☆ Stocks making the biggest moves midday: Hertz, Ford, Keurig Dr Pepper and more
▼ + stars: | 2022-09-27 | by ( Michelle Fox | ) www.cnbc.com time to read: +2 min

Check out the companies making the biggest moves midday:Hertz — Shares of the rental rental company jumped 1.9% after the company announced a partnership with BP's electric vehicle charging unit that will put thousands of charging stations at Hertz locations. Many of the stations will be used to charge Hertz's growing fleet of electric vehicles, but some will be available for public use. Keurig Dr Pepper — The beverage company shed about 3% after being downgraded by Goldman Sachs to a neutral rating from a buy. Lucid — The electric vehicle stock climbed 1.4% on Tuesday after Cantor Fitzgerald initiated coverage of Lucid with an overweight rating. Ark Invest's Cathie Wood also told CNBC Tuesday she is sticking by her bullish call on Tesla, saying "our confidence couldn't be higher as we see the movement towards electric vehicles accelerates."

☆ Stocks making the biggest moves midday: Change Healthcare, Ford, PayPal, Humana and more
▼ + stars: | 2022-09-20 | by ( Carmen Reinicke | ) www.cnbc.com time to read: +3 min

Change Healthcare – Shares of Change Healthcare jumped 6.4% after a federal judge said that UnitedHealth cannot take over the company. Humana – Shares of health company Humana gained 1% and touched an all-time high a day after the company raised its earnings guidance for the fiscal year. Cognex — Shares of machine vision systems maker Cognex jumped nearly 7% after the company raised its revenue outlook for the current quarter. Olin — The manufacturing company fell 4.6% after issuing its third-quarter EBITDA guidance. MicroStrategy – Shares of software company MicroStrategy fell 4.6% after the company announced that it made its smallest purchase of Bitcoin in two years.

☆ Девять человек стали долларовыми миллиардерами на фоне всеобщей вакцинации от ковида
▼ + stars: | 2021-05-22 | by ( ) nokta.md time to read: +1 min

После начала пандемии коронавируса как минимум девять человек стали долларовыми миллиардерами из-за роста прибыли фармацевтических компаний, которые производят вакцины от ковида. Об этом сообщает Oxfam со ссылкой данные альянса правозащитных и медицинских организаций People Vaccineʼs Alliance. Среди новых миллиардеров наибольшее состояние у генеральных директоров американской компании Moderna Стефана Банселя (4,3 миллиарда) и немецкой BioNTech Угура Шахина (4 миллиарда), передает meduza. Отчет People Vaccineʼs Alliance был опубликован накануне Глобального саммита здравоохранения, прошедшего 21 мая в Италии. В поддержку временной приостановки действия патентов на вакцины выступают США, страны Европы высказываются против.

Persons: CanSino, nokta, Стефан Бансель, Угура Шахин, Тимоти Спрингер, Нубар Афеян, Хуан ЛопесБельмонте, Роберт Лэнджер Organizations: Oxfam People Vaccineʼs Alliance . Moderna, Moderna, Oxfam, Vaccineʼs Alliance, ООН Locations: Италия, США, Европа

☆ Руководители Moderna и BioNTech стали долларовыми миллиардерами на фоне вакцинации от COVID-19
▼ + stars: | 2021-05-22 | by ( ) newsmaker.md time to read: +1 min

С начала пандемии коронавируса как минимум девять человек стали долларовыми миллиардерами из-за роста прибыли фармацевтических компаний, которые производят вакцины от COVID-19. Об этом сообщила международная благотворительная организация Oxfam со ссылкой на данные People’s Vaccine Alliance, передает «Новая газета» 23 мая. xСреди тех, кто стал миллиардерами после начала всеобщей вакцинации, гендиректор американской компании Moderna Стефан Бансель (его состояние, по данным Oxfam, составило $4,3 млрд) и сооснователь и руководитель немецкой компании BioNTech Угур Шахин ($4 млрд). В список новых миллиардеров вошли еще четыре человека, связанных с Moderna — иммунолог Тимоти Спрингер ($2,2 млрд), председатель совета директоров Нубар Афеян ($1,9 млрд), руководитель компании, производящей упаковку для вакцины, Хуан Лопес-Бельмонте ($1,8 млрд) и инвестор Роберт Лэнджер ($1,6 млрд). Международная благотворительная организация Oxfam была основана в 1942 году.

Persons: CanSino, Стефан Бансель, Угур Шахин, Тимоти Спрингер, Нубар Афеян, Хуан ЛопесБельмонте, Роберт Лэнджер, Чжу Тао, Цю Дунсу, Мао Хуайхуа Organizations: Oxfam People’s Vaccine, Oxfam, Moderna, —, People Vaccineʼs Alliance, Новая газета Locations: Moderna, Италия

☆ ВОЗ разрешила использование вакцины от Moderna
▼ + stars: | 2021-05-01 | by ( ) nokta.md time to read: +1 min

Вакцина Moderna пополняет постоянно растущий список вакцин, одобренных ВОЗ для использования в чрезвычайных ситуациях. Сегодня ВОЗ внесла в список вакцину Moderna COVID-19 (мРНК 1273) для использования в экстренных случаях, что делает ее пятой вакциной, получившей экстренную валидацию ВОЗ. Вакцина уже была рассмотрена Стратегической консультативной группой экспертов ВОЗ по иммунизации (SAGE), которая дает рекомендации по использованию вакцин среди населения (т.е. Вакцина Moderna — это вакцина на основе mNRA. ВОЗ также внесла в список вакцины Pfizer / BioNTech, Astrazeneca-SK Bio, Serum Institute of India и Janssen для экстренного использования.

Persons: India Janssen, nokta Organizations: Moderna, SAGE, mNRA, Pfizer, BioNTech, Astrazeneca, SK, Serum Institute, India, ВОЗ, Всемирная организация здравоохранения, Стратегическая консультативная группа экспертов, Европейское агентство по лекарственным средствам Locations: США, Европейский союз

☆ СМИ узнали о планах ЕС подать в суд на AstraZeneca
▼ + stars: | 2021-04-27 | by ( ) nokta.md time to read: +1 min

Еврокомиссия (ЕК) намерена подать в суд на британо-шведскую компанию AstraZeneca из-за невыполнения обещаний по поставкам вакцины против коронавируса. Крайний срок, к которому страны ЕС должны дать согласие на начало разбирательства в суде, наступит уже на этой неделе. «В прошлую пятницу Комиссия начала судебный процесс против AstraZeneca», — заявил на пресс-конференции представитель ЕС, отметив, что все 27 стран ЕС поддержали этот шаг. После объявления о судебном иске AstraZeneca заявила, что к концу апреля поставит почти 50 миллионов доз, предусматривающей поставку только 100 миллионов доз к концу апреля. Согласно контракту, британо-шведская компания обязалась приложить «все разумные усилия» для доставки 180 миллионов доз вакцины в ЕС во втором квартале этого года, в общей сложности 300 миллионов в период с декабря по июнь.

Organizations: Еврокомиссия (ЕК), Европейская комиссия, Комиссия Locations: ЕС, Евросоюз

☆ (DOC) Правительство направило письмо Pfizer: Планируется закупить 400 000 доз вакцины. На оферту компании дали 4 дня
▼ + stars: | 2021-03-23 | by ( ) nokta.md time to read: +1 min

Республика Молдова предоставила крупным производителям вакцин 4 дня, чтобы они сделали нам предложение на 400 000 доз. Будем надеяться, что все это крупное производство сможет сделать за 4 рабочих дня«, — говорится в заявлении депутата на facebook. На заседании 11 марта правительство выделило 60 млн леев на закупку около 333 тысяч доз вакцины. При несложном подсчете власти Молдовы готовы предложить максимум 10 долларов за дозу вакцины. В настоящее время вакцина AstraZeneca продается по цене около 2,5 долларов за дозу, Pfizer стоит около 14,5 долларов за дозу, а Moderna — по 18 долларов за дозу.

Persons: Dan Perciun, Дан Перчун Organizations: PAS, Pfizer, Moderna, Sputnik, AstraZeneca Locations: Республика Молдова, Молдова

☆ Великобритания стала первой страной в мире, которая одобрила использование вакцины Pfizer от коронавируса
▼ + stars: | 2020-12-02 | by ( ) ru.diez.md time to read: +1 min

Великобритания стала первой страной в мире, которая одобрила использование вакцины Pfizer от коронавирусаВеликобритания стала первой страной в мире, которая одобрила для массового использования вакцину от коронавируса, разработанную совместной американской компании Pfizer и немецкой BioNTech. После нескольких месяцев клинических испытаний эксперты ведомства пришли к выводу, что вакцина «соответствует строгим стандартам безопасности, качества и эффективности». Ранее компании Pfizer и BioNTech сообщали, что их вакцина BNT162b2 показала 95% эффективность по итогам третьей фазы исследований. (Для сравнения: разработчики российского «Спутника V» оценили эффективность своей вакцины в 92%, американская компания Moderna — в 94,1%, компания AstraZeneca — в 70%.) Pfizer и BioNTech также подавали заявку на регистрацию вакцины в США.

Locations: Великобритания, США

☆ Вакцина против коронавируса компании Pfizer оказалась эффективной для людей старше 65 лет
▼ + stars: | 2020-11-18 | by ( ) newsmaker.md time to read: +2 min

Разработанная компаниями Pfizer и BioNTech вакцина против коронавируса одинаково хорошо переносится независимо от возраста и этнического происхождения вакцинируемого. Таким образом, к выпуску почти готовы три вакцины — Pfizer, «Спутник-V» и Moderna. На прошлой неделе Pfizer и BioNTech опубликовали предварительное заключение о том, что их их препарат обеспечивает защиту против коронавируса с эффективностью 90% и что она практически безопасна. Гамалеи, составляет 92%, а американская компания Moderna сообщила что эффективность ее вакцины 94,5%Для перевозки вакцин нужны особые условия. Со своей стороны Pfizer также начал работу над форматом перевозки: в компании создали боксы с контролем температуры и GPS-управлением.

Organizations: ВВС, Институт им. Гамалеи, Украинская правда Locations: США

Search resuls for: "Moderna —"

23 mentions found